Cargando...
Recent Advances in Prostate Cancer Treatment and Drug Discovery
Novel drugs, drug sequences and combinations have improved the outcome of prostate cancer in recent years. The latest approvals include abiraterone acetate, enzalutamide and apalutamide which target androgen receptor (AR) signaling, radium-223 dichloride for reduction of bone metastases, sipuleucel-...
Guardado en:
| Publicado en: | Int J Mol Sci |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5983695/ https://ncbi.nlm.nih.gov/pubmed/29734647 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19051359 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|